Literature DB >> 29344688

Inflammation-Based Prognostic Score Predicts Postoperative Survival of Patients with Interstitial Pneumonia After Undergoing Lung Cancer Resection.

Satoru Kobayashi1, Yuji Matsumura2, Yoko Karube1, Morimichi Nishihira1, Takashi Inoue1, Osamu Araki1, Sumiko Maeda1, Masayuki Chida1.   

Abstract

OBJECTIVES: Idiopathic interstitial pneumonias (IIPs) are associated with an increased risk of lung cancer. Glasgow prognostic score (GPS), which uses serum C-reactive protein (CRP) and albumin levels to indicate systemic inflammatory response and nutrition level, has been reported to be a predictor of overall survival in patients with various types of cancer. We evaluated the usefulness of GPS for prediction of survival of patients with both lung cancer and IIPs following a lung resection procedure.
METHODS: Patients with IIPs who underwent lung cancer resection from January 2006 through December 2015 were investigated. Routine laboratory measurements, including serum CRP and albumin for determining GPS, were performed before the operation. Univariate and multivariate analyses with a COX proportional hazards regression model were used to identify independent risk factors for overall survival (OS), relapse-free survival (RFS), cancer-specific survival (CSS), and other disease-specific survival (ODSS).
RESULTS: A total of 135 patients underwent lung resection during the study period. Multivariate analysis selected sublobar resection (p = 0.035), UIP pattern (p = 0.025), and GPS of 1-2 (p = 0.042) as predictive factors associated with OS, while GPS of 1-2 (p = 0.039) was shown to be a predictive factor associated with RFS. Multivariate analysis also revealed pTNM (p < 0.001), usual interstitial pneumonia pattern (p = 0.006), and GPS of 2 (p = 0.003) as predictive factors associated with CSS, while univariate analysis indicated pTNM (p = 0.042), GPS of 1 (p = 0.044), and %DLCO (p = 0.038) as predictive factors associated with ODSS.
CONCLUSION: GPS is an independent prognostic factor of OS and RFS in lung cancer patients with IIPs undergoing a lung resection procedure. Furthermore, a GPS of 2 was found to be associated with CSS following lung cancer resection, while a score of 1 was associated with ODSS.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29344688     DOI: 10.1007/s00268-017-4426-4

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  19 in total

1.  Subclinical idiopathic pulmonary fibrosis is also a risk factor of postoperative acute respiratory distress syndrome following thoracic surgery.

Authors:  Masayuki Chida; Shuichi Ono; Yasushi Hoshikawa; Takashi Kondo
Journal:  Eur J Cardiothorac Surg       Date:  2008-08-21       Impact factor: 4.191

2.  Usefulness of Inflammation-Based Prognostic Score in Patients Undergoing Lung Metastasectomy for Colorectal Carcinoma.

Authors:  Satoru Kobayashi; Yoko Karube; Morimichi Nishihira; Takashi Inoue; Osamu Araki; Tetsu Sado; Masayuki Chida
Journal:  World J Surg       Date:  2016-07       Impact factor: 3.352

3.  Postoperative pyothorax a risk factor for acute exacerbation of idiopathic interstitial pneumonia following lung cancer resection.

Authors:  Satoru Kobayashi; Yoko Karube; Morimichi Nishihira; Takashi Inoue; Osamu Araki; Sumiko Maeda; Tetsu Sado; Yuji Matsumura; Masayuki Chida
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-06-08

Review 4.  Incidence of acute exacerbation of interstitial pneumonia in operated lung cancer: institutional report and review.

Authors:  Masayuki Chida; Satoru Kobayashi; Yoko Karube; Makio Hayama; Motohiko Tamura; Hiromi Ishihama; Takeshi Oyaizu
Journal:  Ann Thorac Cardiovasc Surg       Date:  2012-03-24       Impact factor: 1.520

5.  Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival.

Authors:  Jane A Read; S T Boris Choy; Philip J Beale; Stephen J Clarke
Journal:  Nutr Cancer       Date:  2006       Impact factor: 2.900

6.  Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer.

Authors:  Paul Glen; Nigel B Jamieson; Donald C McMillan; Ross Carter; Clem W Imrie; Colin J McKay
Journal:  Pancreatology       Date:  2006-07-13       Impact factor: 3.996

7.  Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer.

Authors:  Toshihiko Sato; Satoshi Teramukai; Haruhiko Kondo; Atsushi Watanabe; Masahito Ebina; Kazuma Kishi; Yoshitaka Fujii; Tetsuya Mitsudomi; Masahiro Yoshimura; Tomohiro Maniwa; Kenji Suzuki; Kazuhiko Kataoka; Yukihiko Sugiyama; Takashi Kondo; Hiroshi Date
Journal:  J Thorac Cardiovasc Surg       Date:  2013-11-20       Impact factor: 5.209

8.  Systemic inflammation predicts all-cause mortality: a glasgow inflammation outcome study.

Authors:  Michael J Proctor; Donald C McMillan; Paul G Horgan; Colin D Fletcher; Dinesh Talwar; David S Morrison
Journal:  PLoS One       Date:  2015-03-02       Impact factor: 3.240

9.  Impact of idiopathic pulmonary fibrosis on advanced non-small cell lung cancer survival.

Authors:  Nobuhiro Kanaji; Akira Tadokoro; Nobuyuki Kita; Makiko Murota; Tomoya Ishii; Takehiro Takagi; Naoki Watanabe; Yasunori Tojo; Shingo Harada; Yusuke Hasui; Norimitsu Kadowaki; Shuji Bandoh
Journal:  J Cancer Res Clin Oncol       Date:  2016-06-27       Impact factor: 4.553

10.  Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer.

Authors:  A B C Crumley; D C McMillan; M McKernan; A C McDonald; R C Stuart
Journal:  Br J Cancer       Date:  2006-03-13       Impact factor: 7.640

View more
  3 in total

1.  Serum Carcinoembryonic Antigen Level Predicts Cancer-Specific Outcomes of Resected Non-Small Cell Lung Cancer With Interstitial Pneumonia.

Authors:  Masaki Tomita; Takanori Ayabe; Ryo Maeda; Kunihide Nakamura
Journal:  World J Oncol       Date:  2018-11-23

2.  Prognostic and Predictive Value of Circulating Inflammation Signature in Non-Metastatic Nasopharyngeal Carcinoma: Potential Role for Individualized Induction Chemotherapy.

Authors:  Shu-Hui Lv; Wang-Zhong Li; Hu Liang; Guo-Ying Liu; Wei-Xiong Xia; Yan-Qun Xiang
Journal:  J Inflamm Res       Date:  2021-05-25

3.  Serum amyloid A protein in cancer prognosis: a meta-analysis and systematic review.

Authors:  Yucheng Lai; Yuting Li; Leilei Gao
Journal:  Transl Cancer Res       Date:  2021-05       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.